(Q77696280)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Cost-effectiveness of statins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

D M Huse

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M W Russell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J D Miller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

D F Kraemer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S C Hartz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

1357-1363

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

A model for evaluating the cost-effectiveness of cholesterol-lowering treatment

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900641-9

Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900641-9

Cost-effectiveness of drug therapy for hypercholesterolaemia: a review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900641-9

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900641-9

Direct medical costs of coronary artery disease in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900641-9

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 6. Cost effectiveness of assessment and management of risk factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900641-9

Cost-effective choice of antimicrobial therapy for serious infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900641-9

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900641-9

Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900641-9

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900641-9

Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900641-9

Estimation of CHD risk in a French working population using a modified Framingham model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900641-9

10.1016/S0002-9149(98)00641-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856919%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference